News Instil Bio, Inc.

Equities

TIL

US45783C2008

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
11.5 ^USD	-2.54%		-0.69%	+50.92%

May. 13	Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating	MT
May. 10	Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Adjusts Price Target on Instil Bio to $32 From $54, Maintains Outperform Rating	May. 13	MT
Instil Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 10	AQ
Instil Bio, Inc. Announces Board Changes	Apr. 26	CI
North American Morning Briefing : Stock Futures -2-	Apr. 15	DJ
Jefferies Downgrades Instil Bio to Hold From Buy	Apr. 12	MT
Instil Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 21	AQ
Instil Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
Instil Bio Announces Strategic Update	Jan. 16	AQ
Instil Bio, Inc. Enters into Agreement with A Collaboration to Conduct Preclinical Manufacturing Feasibility Studies in the ITIL-306 Program	Jan. 16	CI
Instil Bio, Inc. Announces the Closure of Its UK Manufacturing and Clinical Operations	Jan. 16	CI
Instil Bio, Inc.(NasdaqCM:TIL) dropped from NASDAQ Biotechnology Index	Dec. 15	CI
Instil Bio Says 1-for-20 Reverse Stock Split to Take Effect on Dec. 7	Dec. 06	MT
Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split	Dec. 05	AQ
Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 13	AQ
Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual Meeting	Nov. 06	AQ
Instil Bio, Inc.(NasdaqCM:TIL) dropped from S&P Global BMI Index	23-09-18	CI
Instil Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Instil Bio, Inc.

Equities

TIL

US45783C2008

Summary

Filters